The U.S. donated another 6.2 million doses of Pfizer’s COVID-19 vaccine to Bangladesh via COVAX, sustaining the effort to expand vaccinations among youth and hard-to-reach communities. These latest donations from the American people bring the total U.S. government vaccine contribution to more than 51 million doses, with many millions more scheduled to arrive over the coming months.
“We applaud the Government of Bangladesh for recently surpassing the milestone of reaching 100 million people with at least one dose of the COVID-19 vaccine. The United States will continue to donate life-saving vaccines and provide support to help Bangladesh reach the goal of fully vaccinating 70 percent of the country by the middle of 2022,” said U.S. Embassy Chargé d’Affaires Helen LaFave.
In addition to vaccine donations, the United States continues to work closely with Bangladesh to support the national COVID-19 vaccination campaign. The United States has provided training to over 7,000 healthcare providers on proper vaccination management, supported cold-chain storage and transportation, and assisted with targeted campaigns to vaccinate students and hard-to-reach people.
To date, the United States has contributed over US$121 million in COVID-related development and humanitarian assistance through U.S. Agency for International Development, the U.S. Department of Defense, the U.S. Department of State, and the U.S. Centers for Disease Control and Prevention.
This assistance has saved lives and treated individuals infected with COVID-19, strengthened testing capacity and monitoring, enhanced case management and infection prevention and control practices, and improved supply chain and logistics management systems. U.S. support has also protected front line workers and increased the public’s knowledge on how to better protect themselves from infection.
The United States has donated $4 billion to support the worldwide COVAX effort, which includes support for ultra-cold chain storage, transportation, and safe handling of COVID-19 vaccines, making the United States the world’s largest donor for equitable global COVID-19 vaccine access.